Pharma-Bio Serv (PBSV) Share-based Compensation (2010 - 2026)
Pharma-Bio Serv (PBSV) reported Share-based Compensation of $8619.0 for Q2 2026, down 13.81% year-over-year from $10000.0 in Q2 2025, and little changed on a QoQ basis from $8619.0 in Q1 2026.
Pharma-Bio Serv (PBSV) Share-based Compensation (2010 - 2026) Analysis & Trends
Pharma-Bio Serv's Share-based Compensation history runs 17 years deep, the most recent figure standing at $8619.0 for Q2 2026.
- Share-based Compensation for Q2 2026 came in at $8619.0, down 13.81% year-over-year; the trailing twelve-month figure through Apr 2026 was $31636.0 (down 18.1% YoY), and the FY2025 annual result was $35079.0, down 26.22% from the prior year.
- Share-based Compensation came in at $8619.0 for Q2 2026 at Pharma-Bio Serv, roughly flat from $8619.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $28445.0 in Q4 2022 to a low of $684.0 in Q4 2023.
- A 5-year average of $12032.9 and a median of $14399.5 in 2022 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation plunged 97.6% in 2023 and jumped 359.94% in 2024, its largest moves.
- Over 5 years, Share-based Compensation stood at $28445.0 in 2022, then plunged by 97.6% to $684.0 in 2023, then jumped by 359.94% to $3146.0 in 2024, then soared by 39.83% to $4399.0 in 2025, then soared by 95.93% to $8619.0 in 2026.
- The last three Share-based Compensation figures came in at $8619.0 (Q2 2026), $8619.0 (Q1 2026), and $4399.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 119.26 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 3.68 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 19.41 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 11.69 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 22.64 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 36.74 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 11.45 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 21.92 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 9.50 Mn |
| 10 | Pharma-Bio Serv | - | - | 902,041.00 | 8,619.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 8,619.00 |
| Apr 30, 2026 | 8,619.00 |
| Jan 31, 2026 | 8,619.00 |
| Jan 31, 2026 | 8,619.00 |
| Oct 31, 2025 | 4,399.00 |
| Oct 31, 2025 | 4,399.00 |
| Jul 31, 2025 | 9,999.00 |
| Jul 31, 2025 | 9,999.00 |
| Apr 30, 2025 | 10,000.00 |
| Apr 30, 2025 | 10,000.00 |
| Jan 31, 2025 | 10,681.00 |
| Jan 31, 2025 | 10,681.00 |
| Oct 31, 2024 | 3,146.00 |
| Oct 31, 2024 | 3,146.00 |
| Jul 31, 2024 | 14,800.00 |
| Jul 31, 2024 | 14,800.00 |
| Apr 30, 2024 | 14,800.00 |
| Apr 30, 2024 | 14,800.00 |
| Jan 31, 2024 | 14,800.00 |
| Jan 31, 2024 | 14,800.00 |